Pharmacological effects of (+)-nantenine, an alkaloid isolated from Platycapnos spicata, in several rat isolated tissues.
In this work, the potential activity of (+)-nantenine (a natural aporphin alkaloid) in several rat isolated tissues was studied. In rat isolated intact aorta, (+)-nantenine (0.05 - 0.5 microM) competitively antagonized with almost equal effectiveness the contractions produced by phenylephrine (PE) and 5-hydroxytryptamine (5-HT) in normal Krebs solution. However, at higher concentrations (2 microM), the alkaloid also reduced the maximal effect induced by these two agonists. In depolarizing Ca2+-free high KCl 50 mM solution, (+)-nantenine (1.5 - 6 microM) inhibited, in a non-competitive way, the increase in tension evoked by Ca2+ with depression of the maximum response. On the other hand, (+)-nantenine (3 - 30 microM) did not affect the contractile effect caused by okadaic acid (OA, 1 microM) while, however, this alkaloid totally relaxed, in a concentration-dependent fashion, the contractions produced by phorbol 12-myristate 13-acetate (PMA, 1 microM) in endothelium-containing rat aortic rings. (+)-Nantenine (1 - 30 microM) reversed and competitively antagonized the inhibitory action induced by B-HT 920 in electrically-stimulated rat vas deferens. In isolated rat atria, (+)-nantenine (3 - 10 microM) diminished the contraction frequency. (+)-Nantenine (3 microM) significantly reduced the depolarization (voltage)-activated transient (T-type) and sustained (long-lasting, L-type) barium inward currents [ IBa(T) and IBa(L) ] recorded in whole cell-clamped rat aortic myocytes. These results indicate that the pharmacological effects of (+)-nantenine observed at concentrations lower than 1 microM can be attributed to alpha 1 -adrenergic and 5-HT 2A receptor blocking properties whereas at higher concentrations (> 1 microM) the pharmacological activity of this natural compound may be also due to a decrease of Ca2+ influx through transmembrane calcium channels (calcium antagonist activity), to an inhibition of PKC actions and/or to an alpha 2 -adrenoceptor blockade.